Results 81 to 90 of about 756 (101)

A real-world study to evaluate effectiveness of mepolizumab in treating severe asthma in Taiwan (REMIT)

Therapeutic Advances in Respiratory Disease
Background: REMIT is the first real-world study of mepolizumab effectiveness in patients with severe asthma (SA) in Taiwan. Objectives: The primary objective evaluated changes in clinically significant exacerbations (CSEs; defined as use of oral ...
Shih-Lung Cheng, Shu-Min Lin, Chung-Kan Peng, Ming-Cheng Chan, Sheng-Yeh Shen, Ping-Hung Kuo, Chien-Hao Lai, Chou-Chin Lan, Chung-Yu Chen, Ching-Hsiung Lin, Kuang-Ming Liao, Po-Hao Feng, Jiin-Torng Wu, Yu-Feng Wei, Xiaomeng Xu, Rafael Alfonso-Cristancho, Tina Lai, Aldo Navarro, Dominique Milea, Diahn-Warng Perng   +19 more
doaj   +1 more source

Real-World Impact of Mepolizumab in COPD in a US Commercial and Medicare Claims Database

International Journal of COPD
Reynold A Panettieri,1,2 Rosirene Paczkowski,3 Hannah Mei,3 Emmeline Burrows,4 Guillaume Germain,5 Sunay Shah,6 Jacob Klimek,7 Sophie Ma,5 Sarah Cooper,7 François Laliberté,5 Antonio Anzueto81Rutgers Institute for Translational Medicine and Science, The ...
Panettieri RA, Paczkowski R, Mei H, Burrows E, Germain G, Shah S, Klimek J, Ma S, Cooper S, Laliberté F, Anzueto A   +10 more
doaj  

Some of the next articles are maybe not open access.

Related searches:

Real-world Effectiveness of Mepolizumab in Severe Eosinophilic Asthma: A Systematic Review and Meta-analysis

Clinical Therapeutics, 2021
Jiangtao Lin, Shuhua Zhang
exaly  

Efficacy of mepolizumab in usual clinical practice and characteristics of responders

Respiratory Medicine, 2021
Francisco Javier González Barcala, Juan J Nieto-Fontarigo, Carlota Rodríguez-García   +2 more
exaly  

Clinical Development of Mepolizumab for the Treatment of Severe Eosinophilic Asthma: On the Path to Personalized Medicine

Journal of Allergy and Clinical Immunology: in Practice, 2021
Andrew Menzies-Gow, Njira Lugogo, Ian D. Pavord   +2 more
exaly  

Mepolizumab Improves Outcomes of Chronic Rhinosinusitis with Nasal Polyps in Severe Asthmatic Patients: A Multicentric Real-Life Study

Journal of Personalized Medicine, 2022
Eugenio De Corso, Veronica Seccia, Angela Rizzi   +2 more
exaly  

Top bar navigation

Frontiers in Pharmacology, 2023
Yuanbo Lan, Yingyong Ou, Junyou Chen
exaly  

Extension of mepolizumab injection intervals as potential of saving costs in well controlled patients with severe eosinophilic asthma

World Allergy Organization Journal, 2022
Karl-Christian Bergmann, Torsten Zuberbier, Jean Bousquet   +2 more
exaly  

Long-term Safety and Clinical Benefit of Mepolizumab in Patients With the Most Severe Eosinophilic Asthma: The COSMEX Study

Clinical Therapeutics, 2019
Robert G Price, Guy Brusselle, Frank Albers   +2 more
exaly  

Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial

Lancet, The, 2012
Hector Ortega, Ian D. Pavord, Eugene R Bleecker   +2 more
exaly